A detailed history of Boston Financial Mangement LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Boston Financial Mangement LLC holds 31,608 shares of ABBV stock, worth $5.55 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
31,608
Previous 30,324 4.23%
Holding current value
$5.55 Million
Previous $5.2 Million 20.0%
% of portfolio
0.19%
Previous 0.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$163.84 - $199.33 $210,370 - $255,939
1,284 Added 4.23%
31,608 $6.24 Million
Q2 2024

Jul 29, 2024

SELL
$154.79 - $180.76 $83,122 - $97,068
-537 Reduced 1.74%
30,324 $5.2 Million
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $3,196 - $3,642
-20 Reduced 0.06%
30,861 $5.62 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $815,417 - $918,352
5,926 Added 23.75%
30,881 $4.79 Million
Q3 2023

Nov 09, 2023

SELL
$133.59 - $154.65 $34,332 - $39,745
-257 Reduced 1.02%
24,955 $3.72 Million
Q2 2023

Aug 07, 2023

SELL
$132.51 - $164.9 $89,444 - $111,307
-675 Reduced 2.61%
25,212 $3.4 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $532,598 - $613,366
-3,683 Reduced 12.46%
25,887 $4.13 Million
Q4 2022

Jan 27, 2023

BUY
$138.31 - $165.87 $33,747 - $40,472
244 Added 0.83%
29,570 $0
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $221,849 - $254,446
1,653 Added 5.97%
29,326 $3.94 Million
Q2 2022

Aug 08, 2022

BUY
$137.62 - $174.96 $122,757 - $156,064
892 Added 3.33%
27,673 $4.24 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $49,096 - $60,915
372 Added 1.41%
26,781 $4.34 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $99,050 - $125,327
922 Added 3.62%
26,409 $3.58 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $60,222 - $68,361
566 Added 2.27%
25,487 $2.75 Million
Q2 2021

Aug 03, 2021

SELL
$105.21 - $117.21 $213,050 - $237,350
-2,025 Reduced 7.52%
24,921 $2.81 Million
Q1 2021

May 07, 2021

SELL
$102.3 - $112.62 $363,369 - $400,026
-3,552 Reduced 11.65%
26,946 $2.92 Million
Q4 2020

Feb 10, 2021

SELL
$80.49 - $108.67 $414,201 - $559,215
-5,146 Reduced 14.44%
30,498 $3.27 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $110,566 - $129,768
-1,287 Reduced 3.48%
35,644 $3.12 Million
Q2 2020

Aug 10, 2020

SELL
$73.37 - $98.18 $18,562 - $24,839
-253 Reduced 0.68%
36,931 $3.63 Million
Q1 2020

May 05, 2020

SELL
$64.5 - $97.79 $410,542 - $622,433
-6,365 Reduced 14.62%
37,184 $2.83 Million
Q4 2019

Feb 05, 2020

SELL
$72.13 - $90.25 $270,920 - $338,979
-3,756 Reduced 7.94%
43,549 $3.86 Million
Q3 2019

Nov 08, 2019

SELL
$62.98 - $75.72 $264,767 - $318,326
-4,204 Reduced 8.16%
47,305 $3.58 Million
Q2 2019

Jul 24, 2019

SELL
$65.7 - $83.98 $496,297 - $634,384
-7,554 Reduced 12.79%
51,509 $3.75 Million
Q1 2019

Apr 25, 2019

SELL
$77.14 - $90.79 $332,010 - $390,760
-4,304 Reduced 6.79%
59,063 $4.76 Million
Q4 2018

Jan 31, 2019

SELL
$77.85 - $96.01 $559,352 - $689,831
-7,185 Reduced 10.18%
63,367 $5.84 Million
Q3 2018

Nov 02, 2018

BUY
$88.91 - $98.84 $386,313 - $429,459
4,345 Added 6.56%
70,552 $6.67 Million
Q2 2018

Aug 03, 2018

SELL
$89.78 - $106.23 $2.66 Million - $3.15 Million
-29,666 Reduced 30.94%
66,207 $6.13 Million
Q1 2018

Apr 25, 2018

SELL
$92.01 - $123.21 $736,540 - $986,296
-8,005 Reduced 7.71%
95,873 $9.07 Million
Q4 2017

Feb 05, 2018

SELL
$89.56 - $98.21 $206,794 - $226,766
-2,309 Reduced 2.17%
103,878 $10 Million
Q3 2017

Oct 30, 2017

BUY
$69.85 - $89.22 $7.42 Million - $9.47 Million
106,187
106,187 $9.44 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Boston Financial Mangement LLC Portfolio

Follow Boston Financial Mangement LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Financial Mangement LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Financial Mangement LLC with notifications on news.